Современные достижения эндоваскулярных технологий в лечении ишемической болезни сердца и периферического атеросклероза
Кардиология
Дата публикации: декабря 20, 2014
Ключевые слова
атеросклероз
ИБС
методы диагностики
эндоваскулярные диагностика и лечение
ИБС
методы диагностики
эндоваскулярные диагностика и лечение
Как цитировать
[1]
Е. Яшина, А. Агапов, Т. Балахонова, Б. Руденко, и Е. Коровина, Современные достижения эндоваскулярных технологий в лечении ишемической болезни сердца и периферического атеросклероза, КМКВ, вып. 2, сс. 124-128, дек. 2014.
Аннотация
Обзор текущих достижений эндоваскулярных методовлечения ИБС.Ключевые слова: атеросклероз, ИБС, методы диагно-стики, эндоваскулярные диагностика и лечение.The last achievements of endovascular technologies inthe treatment of the ischemic heart disease and peripheralatherosclerosisE.R. Yashina, A.A. Agapov, T.V. Balakhonova, B.A. Rudenko,E.V. Korovina«Сlinical hospital» of the Department of affairs managementof President of Russian Federation, MoscowSummarySurvey of the current achievements of the endovascularmethods of treatment ischemic heart diseases.Key words: atherosclerosis, ischemic heart diseases,methods of diagnostics, endovascular diagnostics and thetreatment.Литература
1. Serruys P.W., Emanuelsson H., van der Giessen W., et
al: Heparin-coated Palmaz-Schatz stents in human coronary
arteries: Early out-come of the BENESTENT II Pilot Study.
Circulation 1996; 93: 412-422.
2. Sawada Y., Nosaka H., Kimura T., et al: Initial and sixmonth
outcome of Ralmaz-Schatz stent implantation: STRESS/
BENESTENT equivalent versus nonequivalent lesions. J Am
Coll Cardiol 1996; 27 (suppl A): 252 A.
3. Colombo A., Fajadet J., G. Schuler. 365-day follow-up
of the RAVEL study: a randomized study with sirolimus-eluting
BX Velocity balloon-expandable stent. European Heart Journal
2002; 4: Suppl A (264).
4. Morice M-C., Serruys P.W., Sousa J.E. Et al. A
randomized comparison of a sirolimus-eluting stent with a
standart stent for coronary revascularization. N Engl J Med.
2002; 346: 1773-80.
5. The GUSTO Investigators. An International
Randomized Trial Comparing Four Thrombolytic Strategies For
Acute Myocardial Infarction. N Engl J Med 1993;329:673–682.
6. Bode C., Smalling R.W., Berg G., et al. Randomized
comparison of coronary thrombolysis achieved with doublebolus
reteplase (recombinant plasminogen activator) and frontloaded,
accelerated alteplase (recombinant tissue plasminogen
activator) in patients with acute myocardial infarction.Circulation
1996;94:891–898.
7. Llevadot J., Giugliano R.P., McCabe C.H., et al.
Degree of residual stenosis in the culprit coronaryartery after
thrombolytic administration (Thrombolysis in Myocardial
Infarction [TIMI] Trials). Am J Cardiol 2000;85:1409–1413.
8. Weaver W.D., Simes R.J., Betriu A., et al. Comparison
of primary coronary angioplasty and intravenous thrombolytic
therapy for acute myocardial infarction: a quantitative review.
JAMA 1997;278:2093–2098.
9. Boersma E., Mercado N., Poldermans D., et al: Acute
myocardial infarction. Lancet 2003; 361:847.
10. Franzosi M.G., Santoro E., De Vita C, Geraci E., Lotto
A., Maggioni A.P., Mauri F., Rovelli F., Santoro L., Tavazzi L.,
Tognoni G.: Ten-year follow-up of the first megatrial testing
thrombolytic therapy in patients with acute myocardial infarction:
results of the Gruppo Italiano per lo Studio della Sopravvivenza
nell'Infarto-1 study. The GISSI Investigators. Circulation 1998;
98:2659-2665.
11. Gurwitz J.H., Gore J.M., Goldberg R.J., et al. Risk
for intracranial hemorrhage after tissue plasminogen activator
treatment for acute myocardial infarction. Ann Intern Med
1998;129: 597–604.
12. Stone G.W., O’Neill W.W., Jones B., Grines C.L. The
central unifying concept of TIMI-3 flow after primary PTCA in
thrombolytic therapy in acute myocardial infarction. Circulation
1996;94(Suppl I):I-515 (abstract).
13. The Global Use of Strategies to Open Occluded Coronary
Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty
Substudy Investigators. A clinical trial comparing primary coronary
angioplasty with tissue plasminogen activator for acute myocardial
infarction. N Engl J Med 1997;336:1621–1628.
14. O’Neill W.W., Brodie B.R., Ivanhoe R., et al. Primary
coronary angioplasty for acute myocardial infarction (The
Primary Angioplasty Registry). Am J Cardiol 1994;73:627–634.
15. Grines C.L., Cox D.A., Stone G.W., et al. Coronary
angioplasty with or without stent implantation for acute
myocardial infarction. N Engl J Med 1999;341:1949–1956.
16. Weaver W.D., Simes RJ, Betriu A, et al. Comparison
of primary coronary angioplasty and intravenous thrombolytic
therapy for acute myocardial infarction: a quantitative review.
JAMA 1997;278:2093–2098.
17. Grines C.L., Serruys P, O'Neill WW: Fibrinolytic
therapy: Is it a treatment of the past? Circulation 2003;
107:2538.
18. The GUSTO Investigators. An International
Randomized Trial Comparing Four Thrombolytic Strategies For
Acute Myocardial Infarction. N Engl J Med 1993;329:673–682.
19. Varani E., Balducelli M., Vecchi G., Aquilina M., Maresta
A. Comparison of multiple drug-eluting stent percutaneous
coronary intervention and surgical revascularization in patients
with multivessel coronary artery disease: one-year clinical results
and total treatment costs. J Invasive Cardiol. 2007;19(11):476-7.
20. Yang H, Gwon H, Cho S, et al. Comparison of coronary
artery bypass grafting with drug-eluting stent implantation for
the treatment of multivessel coronary artery disease. Ann Thorac
Surg. 2008;85(1):25-7.
21. Stone G., Kandrazi D., Mehran R. Percutaneous
Recanalization of Chronically Occluded Coronary Arteries.
Circulation 2005; 112: 2364 – 2372.
22. Sanmartin M., Baz J.A., Claro R. et al. Comparison
of drug-eluting stents versus surgery for unprotected left main
coronary artery disease. Am J Cardiol. 2007;100(6):970-3.
23. Yan A., Tan M. One-year outcome of patients after
acute coronary syndromes (from the Canadian Acute Coronary
Syndromes Registry). Am J Cardiol 2005; 95: 438
24. Furman M., Dauerman H., Robert J. Twenty-two year
(1975 to 1997) trends in the incidence, in-hospital and long-term
case fatality rates from initial q-wave and non-q-wave myocardial
infarction: a multi-hospital, community-wide perspective. J Am
Coll Cardiol 2001; 37: 1571-1580.
25. Савченко А.П., Руденко Б.А., Болотов П.А. Срав-
нительный анализ рентгеноморфологии и успешности
эндоваскулярных вмешательств у больных в госпиталь-
ном периоде инфаркта миокарда и через 6 месяцев. Вест-
ник рентгенологии и радиологии 2006; 4: 4–12.
26. Suero J.A. et al. Procedural outcomes and long-term
survival among patients undergoing percutaneous coronary
intervention of a chronic total occlusion in native coronary
artery: a 20-year experience.J Am Coll Cardiol 2001;38: 406-9.
27. Stone G., Kandrazi D., Mehran R.. Percutaneous
Recanalization of Chronically Occluded Coronary Arteries.
Circulation 2005; 112: 2364 – 2372.
28. Yadav J. S. et al. SAPPHIRE trial. N Eng J Med 2004;
351:1495 – 501.
al: Heparin-coated Palmaz-Schatz stents in human coronary
arteries: Early out-come of the BENESTENT II Pilot Study.
Circulation 1996; 93: 412-422.
2. Sawada Y., Nosaka H., Kimura T., et al: Initial and sixmonth
outcome of Ralmaz-Schatz stent implantation: STRESS/
BENESTENT equivalent versus nonequivalent lesions. J Am
Coll Cardiol 1996; 27 (suppl A): 252 A.
3. Colombo A., Fajadet J., G. Schuler. 365-day follow-up
of the RAVEL study: a randomized study with sirolimus-eluting
BX Velocity balloon-expandable stent. European Heart Journal
2002; 4: Suppl A (264).
4. Morice M-C., Serruys P.W., Sousa J.E. Et al. A
randomized comparison of a sirolimus-eluting stent with a
standart stent for coronary revascularization. N Engl J Med.
2002; 346: 1773-80.
5. The GUSTO Investigators. An International
Randomized Trial Comparing Four Thrombolytic Strategies For
Acute Myocardial Infarction. N Engl J Med 1993;329:673–682.
6. Bode C., Smalling R.W., Berg G., et al. Randomized
comparison of coronary thrombolysis achieved with doublebolus
reteplase (recombinant plasminogen activator) and frontloaded,
accelerated alteplase (recombinant tissue plasminogen
activator) in patients with acute myocardial infarction.Circulation
1996;94:891–898.
7. Llevadot J., Giugliano R.P., McCabe C.H., et al.
Degree of residual stenosis in the culprit coronaryartery after
thrombolytic administration (Thrombolysis in Myocardial
Infarction [TIMI] Trials). Am J Cardiol 2000;85:1409–1413.
8. Weaver W.D., Simes R.J., Betriu A., et al. Comparison
of primary coronary angioplasty and intravenous thrombolytic
therapy for acute myocardial infarction: a quantitative review.
JAMA 1997;278:2093–2098.
9. Boersma E., Mercado N., Poldermans D., et al: Acute
myocardial infarction. Lancet 2003; 361:847.
10. Franzosi M.G., Santoro E., De Vita C, Geraci E., Lotto
A., Maggioni A.P., Mauri F., Rovelli F., Santoro L., Tavazzi L.,
Tognoni G.: Ten-year follow-up of the first megatrial testing
thrombolytic therapy in patients with acute myocardial infarction:
results of the Gruppo Italiano per lo Studio della Sopravvivenza
nell'Infarto-1 study. The GISSI Investigators. Circulation 1998;
98:2659-2665.
11. Gurwitz J.H., Gore J.M., Goldberg R.J., et al. Risk
for intracranial hemorrhage after tissue plasminogen activator
treatment for acute myocardial infarction. Ann Intern Med
1998;129: 597–604.
12. Stone G.W., O’Neill W.W., Jones B., Grines C.L. The
central unifying concept of TIMI-3 flow after primary PTCA in
thrombolytic therapy in acute myocardial infarction. Circulation
1996;94(Suppl I):I-515 (abstract).
13. The Global Use of Strategies to Open Occluded Coronary
Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty
Substudy Investigators. A clinical trial comparing primary coronary
angioplasty with tissue plasminogen activator for acute myocardial
infarction. N Engl J Med 1997;336:1621–1628.
14. O’Neill W.W., Brodie B.R., Ivanhoe R., et al. Primary
coronary angioplasty for acute myocardial infarction (The
Primary Angioplasty Registry). Am J Cardiol 1994;73:627–634.
15. Grines C.L., Cox D.A., Stone G.W., et al. Coronary
angioplasty with or without stent implantation for acute
myocardial infarction. N Engl J Med 1999;341:1949–1956.
16. Weaver W.D., Simes RJ, Betriu A, et al. Comparison
of primary coronary angioplasty and intravenous thrombolytic
therapy for acute myocardial infarction: a quantitative review.
JAMA 1997;278:2093–2098.
17. Grines C.L., Serruys P, O'Neill WW: Fibrinolytic
therapy: Is it a treatment of the past? Circulation 2003;
107:2538.
18. The GUSTO Investigators. An International
Randomized Trial Comparing Four Thrombolytic Strategies For
Acute Myocardial Infarction. N Engl J Med 1993;329:673–682.
19. Varani E., Balducelli M., Vecchi G., Aquilina M., Maresta
A. Comparison of multiple drug-eluting stent percutaneous
coronary intervention and surgical revascularization in patients
with multivessel coronary artery disease: one-year clinical results
and total treatment costs. J Invasive Cardiol. 2007;19(11):476-7.
20. Yang H, Gwon H, Cho S, et al. Comparison of coronary
artery bypass grafting with drug-eluting stent implantation for
the treatment of multivessel coronary artery disease. Ann Thorac
Surg. 2008;85(1):25-7.
21. Stone G., Kandrazi D., Mehran R. Percutaneous
Recanalization of Chronically Occluded Coronary Arteries.
Circulation 2005; 112: 2364 – 2372.
22. Sanmartin M., Baz J.A., Claro R. et al. Comparison
of drug-eluting stents versus surgery for unprotected left main
coronary artery disease. Am J Cardiol. 2007;100(6):970-3.
23. Yan A., Tan M. One-year outcome of patients after
acute coronary syndromes (from the Canadian Acute Coronary
Syndromes Registry). Am J Cardiol 2005; 95: 438
24. Furman M., Dauerman H., Robert J. Twenty-two year
(1975 to 1997) trends in the incidence, in-hospital and long-term
case fatality rates from initial q-wave and non-q-wave myocardial
infarction: a multi-hospital, community-wide perspective. J Am
Coll Cardiol 2001; 37: 1571-1580.
25. Савченко А.П., Руденко Б.А., Болотов П.А. Срав-
нительный анализ рентгеноморфологии и успешности
эндоваскулярных вмешательств у больных в госпиталь-
ном периоде инфаркта миокарда и через 6 месяцев. Вест-
ник рентгенологии и радиологии 2006; 4: 4–12.
26. Suero J.A. et al. Procedural outcomes and long-term
survival among patients undergoing percutaneous coronary
intervention of a chronic total occlusion in native coronary
artery: a 20-year experience.J Am Coll Cardiol 2001;38: 406-9.
27. Stone G., Kandrazi D., Mehran R.. Percutaneous
Recanalization of Chronically Occluded Coronary Arteries.
Circulation 2005; 112: 2364 – 2372.
28. Yadav J. S. et al. SAPPHIRE trial. N Eng J Med 2004;
351:1495 – 501.